These alterations were correlated with a decrease in inflammatory cytokines (MCP-1, TNF-α), suggesting a potential suppression of NASH-associated hepatocellular carcinoma. The gene discussed is TNF; the disease is metabolic dysfunction-associated steatohepatitis.